Contact list

Below you can find the contact details for the Project Coordinator, the Co-coordinator, Financial Management, Pillar Leaders, Work Package Leaders, Task Leaders and Chemical Group Leaders. You can also download a list of all contacts in the consortium, and a list of Task Leaders. Should you identify errors or missing individuals, please email HBM4EU@eea.europa.eu to provide updated information.

Download file with list of all the HBM4EU contacts with phone numbers and e-mail addresses (see the version nr. in the file)</a >

Download file with list of task leaders including phone numbers and e-mail addresses</a >
Download file with list of Chemical Group Leaders’ contact point per Workpackage</a >

HBM4EU Coordination

Coordinator:

Marike Kolossa-Gehring Phone: +49 30 8903 1600 Mobile: +49 17 3599 3297
Anja Kiesow Phone: +49 30 8903 2004
Nicole Kobosil Phone: +49 30 8903 1269
Rosa Lange Phone: +49 30 8903 1357
Kim Pack Phone: +49 30 8903 1266
Lena Reiber Phone: +49 30 8903 1265
Pia Splanemann Phone: +49 30 8903 2793
Philipp Weise Phone: +49 30 8903 1222

German Environment Agency (UBA) Section II 1.2 Toxicology, Health
Related Environmental Monitoring Corrensplatz 1, 14195 Berlin POB 33 00 22,
14191 Berlin, Germany E-Mail:
HBM4EU@uba.de

Financial Management:

Birgit Puppe Phone: +49 340 2103 2366

Doreen Scheler Phone: +49 340 2103 2375

German Environment Agency (UBA) Unit Z 6 – Project Administration Wörlitzer
Platz 1, 06844 Dessau-Roßlau POB 1406, 06813 Dessau-Roßlau, Germany E-Mail:
HBM4EU@uba.de

Co-Coordinator:

Greet Schoeters Phone: + 32 14 33 5167 Mobile: +32 477427746

Sylvie Remy Phone: +32 14 33 5511

VITO-Unit Environmental Risk and Health University of Antwerp – Dept.
Biomedical Sciences University of Southern Denmark – Institute of Public
Health/ Dept. of Environmental Medicine Email:
HBM4EU@vito.be

Pillar Leaders

Pillar Leader for Pillar 1 Science to Policy:

Greet Schoeters Phone: + 32 14 33 5167 Mobile: +32 477427746 VITO-Unit
Environmental Risk and Health University of Antwerp – Dept. Biomedical
Sciences University of Southern Denmark – Institute of Public Health/ Dept.
of Environmental Medicine Email:
HBM4EU@vito.be

Pillar Leader for Pillar 2 European HBM Platform:

Argelia Castaño with co-lead Greet Schoeters Phone: +34 918223540 Mobile:
+34 918223545 National Center for Environmental Health Institute of Health
Carlos III, Ctra. Majadahonda a Pozuelo km 2,2 28220-Majadahonda (Madrid),
Spain Email: castano@isciii.es;
hbm4eu@isciii.es

Pillar Leader for Pillar 3 Exposure and Health:

Robert Barouki

Phone: 33 (0)1 42 86 20 75 Unité UMR-S 1124 Inserm-Université Paris
Descartes “Toxicologie Pharmacologie et Signalisation Cellulaire” 45 rue
des Saints Pères, 75270 Paris 06 France Email:
robert.barouki@parisdescartes.fr</a >

Phone: 33 (0)1 44 49 50 55 Service de Biochimie Métabolomique et
Protéomique Hôpital Necker Enfants Malades 149 rue de Sèvres, 75015
Paris, France Email:
robert.barouki@nck.aphp.fr</a >

List of Work Package Leaders

WP Nº	Title	Name	Consortium Partner
1	Programme management and coordination	Marike Kolossa	UBA
2	Knowledge Hub	Catherine Ganzleben	EEA
3	Internal Calls	Robert Barouki	INSERM
4	Prioritisation and input to the annual work plan	Catherine Ganzleben	EEA
5	Translation of results into policy	Greet Schoeters	VITO
6	Sustainability and capacity building	Robert Barouki	INSERM
7	Survey design and fieldwork preparation	Ulrike Fiddicke	UBA
8	Targeted field work surveys and alignment at EU level	Ovnair Sepai	DH
9	Laboratory analysis and quality assurance	Argelia Castaño	ISCIII
10	Data management and analysis	Greet Schoeters	VITO
11	Linking HBM, health studies, and registers	Hanna Tolonen	THL
12	From HBM to exposure	Dimosthenis Sarigiannis	AUTH
13	Establishing exposure health relationships	Jana Klánová	MU
14	Effect Biomarkers	Nicolás Olea	UGR
15	Mixtures, HBM and human health risks	Erik Lebret	RIVM
16	Emerging Chemicals	Jean-Philippe Antignac	INRA
17	Ethics requirements	Ulrike Doyle	UBA

List of Chemical Group Leaders

CGL – partner abbr.	Chemical Substance Group	Name
AUTH	PAHs	Denis Sarigiannis
EAA	Per- and Polyfluorinated Compounds	Maria Uhl, Ingrid Hauzenberger
FIOH	MOCA & Anilines	Tiina Santonen
UCPH	MOCA & Anilines	Lisbeth Knudsen
INSERM	Bisphenols	Robert Barouki
ISS	Cadmium/Chromium VI	Beatrice Bocca
JSI	Cadmium/Chromium VI	Milena Horvat, Janja Snoj Tratnik
MU	Flame retardants	Jana Klánová, Lisa Melymuk

RIVM	Mixtures	Erik Lebret, Mirjam Luijten

UBA	Phthalates & substitutes	Marike Kolossa-Gehring, Rosa Lange
VITO	Emerging chemicals	Greet Schoeters

List of the task Leaders

WP No.	Task No.	Title	First Name	Last name	Institution
1	1.1	Overall administrative and financial management of the programme	Birgit	Puppe	UBA
	1.2	Development of the Annual Work Plans	Kim	Pack	UBA
	1.3	Coordination within and across pillars	Marike	Kolossa-Gehring	UBA
	1.4	Governing Board (GB), Stakeholder Forum (SF), and Advisory Board (AB)	Lena	Reiber	UBA
	1.5	Legal, IPR and ethics framework	Lisbeth E.	Knudsen	UCPH

2	2.1	HBM4EU Website	Catherine	Ganzleben	EEA
	2.2	Strategy for the communication and dissemination of HBM4EU results	Catherine	Ganzleben	EEA
	2.3	Online Library of guidelines, biomarkers, protocols, and research results	Susana	Pedraza-Diaz	ISCIII
	2.4	Outreach to national, EU-level and international projects and contacts	Catherine	Ganzleben	EEA
	2.5	Training	Paul	Scheepers	RUMC

4
	4.1	Mapping the information needs of external bodies	Catherine	Ganzleben	EEA
	4.2	Prioritisation strategy	Jean-Nicolas	Ormsby	ANSES
	4.2	Prioritisation strategy	Christophe	Rousselle	ANSES
	4.3	Rapid response mechanism	Jean-Nicolas	Ormsby	VITO
	4.3	Rapid response mechanism	Christophe	Rousselle	VITO
	4.4	Drafting scoping documents to feed into the annual work plan	Gudrun	Koppen	VITO
	4.4		Greet	Schoeters	VITO

5
	5.1	Collating results by substance	Greet	Schoeters	VITO
	5.2	Development and consolidation of EU level HBM health based guidance values	Petra	Apel	UBA
	5.3	Inclusion of HBM data in risk assessment/health impact assessment strategies	Tiina	Santonen	FIOH
	5.4	Development of indicators using HBM	Joana	Lobo Vicente	EEA
	5.5	(Phased) Action Plan for the use of HBM for policies, measures or further research	Ilse	Loots	Uantwerpen

6
	6.1	Establishment of national framework to feed into HBM4EU	Ovnair	Sepai	DH
	6.2	Funding mechanisms and resources for national capacity building	Ana Patrícia	Lopes Virgolino	FMUL
	6.3	Longer-term needs and expectations of stakeholders	Catherine Joana	Ganzleben Lobo Vicente	EEA
	6.4	Operational architecture concept, research cooperation framework concept, financial plans	Robert	Barouki	INSERM
	6.4		Charles	Persoz	INSERM
	6.5	Indicators for measuring HBM4EU impacts	Karen	Vancampenhout	LNE Department
	6.5	Indicators for measuring HBM4EU impacts	Hans	Reynders	LNE Department
	6.6	Ambassador for a long-term HBM4EU	Robert	Barouki	INSERM

7
	7.1	Identification of existing data and data gaps	Ana Patrícia	Lopes Virgolino	FMUL
			Maria Fátima	Reis	FMUL
			Osvaldo	Rodrigues dos Santos	FMUL
	7.2	Strategy recruitment and sampling	Ulrike	Fiddicke	UBA
	7.2	Strategy recruitment and sampling	Laura-Kim	Pack
	7.3	Questionnaires development	Marina	Lacasaña	EASP
	7.4	Strategy for exchange of human samples	Dominik	Lermen	IBMT
	7.5	Communication of participants	Andromachi	Katsonouri-Sazeides	MOH-CY
			Elena	Anastasi	MOH-CY
			Dora	Partassides	MOH-CY

8
	8.1	Alignment of national studies	Greet	Schoeters	VITO
	8.2	Use of existing samples from biobanks	Marika	Berglund	KI
	8.2	Use of existing samples from biobanks	Ovnair	Sepai	DH
	8.3	Targeted fieldwork with mixtures	Ovnair Lorraine	Sepai Stewart	DH DH
	8.4	Targeted fieldwork combining HES and HBM surveys	Ovnair	Sepai	DH
	8.5	Targeted occupational studies with EU added value	Tiina	Santonen	FIOH
	8.6	Helpdesk	Ovnair	Sepai	DH
	8.6	Helpdesk	Lorraine	Stewart	DH

9
	9.1	Inventory of best suited biomarkers, matrices, and needs for new analytical methods	Cathrine	Thomson	NIPH
			Line Småstuen	Haug	NIPH
			Enrique	Manciñereas Cequier	NIPH
	9.2	Network of Reference HBM laboratories for performing biomarker analysis, developing new methods, and supporting the QA/QC programme at EU level	Argelia	Castaño	ISCIII
	9.2		Marta	Esteban López	ISCIII
	9.3	Developing of new methods	Holger	Koch	IPA
	9.4	Quality Assurance	Thomas	Göen	IPASUM
	9.5	Analytical Phase	Thomas	Lundh	ULUND
	9.5	Analytical Phase	Christian	Lindh	ULUND
	9.6	Help desk	Jana	Hajslova	VSCHT
	9.6	Help desk	Jana	Pulkrabova	VSCHT

10
	10.1	Data management plan	Greet	Schoeters	VITO
			Eva	Govarts	VITO
			Sylvie	Remy	VITO
	10.2	Helpdesk for data management	Greet	Schoeters	VITO
			Eva	Govarts	VITO
			Sylvie	Remy	VITO
	10.3	Development of statistical analysis plans and coordination of analysis	Martine	Vrijheid	ISGlobal
	10.3		Maribel	Casas	ISGlobal
	10.4	Data analysis including the generation of European reference values	Greet	Schoeters	VITO
			Eva	Govarts	VITO
			Sylvie	Remy	VITO
	10.5	Integration of data into IPChem	Catherine	Ganzleben	EEA


11
	11.1	Opportunities and obstacles for linking HBM programmen and health studies	Anna-Maria	Andersson	RegionH
	11.2	Standard operating procedures and guidelines for use of existing biological samples, linking HBM and health surveys	Hanna	Tolonen	THL
	11.3	Workshop on opportunities and obstacles to combinw HBM and health studies	Stefaan	Demarest	WIV-ISP
	11.4	Feasibility studies	Hanna	Tolonen	THL
	11.5	Linking HBM to administrative registries	Helle Margrete	Meltzer	NIPH

12
	12.1	Integrated external and internal exposure modelling	Dimosthenis	Sarigiannis	AUTH
	12.2	Exposure estimation from HBM data and risk characterization	Dimosthenis	Sarigiannis	AUTH
	12.3	Refinement of toxicokinetic modelling, estimation of elimination half-lives	Jana	Klánová	MU

13
	13.1	Knowledge base on causal pathways from chemical exposure to health outcomes	Dimosthenis	Sarigiannis	AUTH
	13.2	Health effects in humans based on birth and adult cohorts	Thórhallur Ingi	Halldórsson	UI

14
	14.1	Inventory of biomarkers of effect	Nicolas	Olea	UGR
	14.1	Inventory of biomarkers of effect	Mariana	Fernández	UGR
	14.2	Selection of biomarkers of effect according their proven utility in human studies	Nicolas	Olea	UGR
	14.2		Mariana	Fernández	UGR
	14.3	Identification of needs for the development of new biomarkers of effect and setting up decision criteria associated with the characteristics of biomarkers and their validation in child and adult cohorts and occupational studies	Nicolas	Olea	UGR
	14.3		Mariana	Fernández	UGR

15
	15.1	Re-analysis of existing data on mixtures from earlier HBM studies using a key set of summary indicators	Erik	Lebret	RIVM
	15.2	Joint survey on HBM mixtures in 3-5 countries	Roel	Vermeulen	IRAS
	15.2	Joint survey on HBM mixtures in 3-5 countries	Jelle	Vlaanderen	IRAS
	15.3	Identification of mixture health effects	Anderas	Kortenkamp	UBRUN

16
	16.1	Make an inventory of emerging chemicals relevant for HBM4EU and for which to date no biomonitoring data exists	Roel	Vermeulen	IRAS
	16.1		Jelle	Vlaanderen	IRAS
	16.2	Method development and harmonisation of methods for (1) suspect screening of known emerging compounds and (2) non-target screening of yet unknown compounds	Jean-Philippe	Antignac	INRA
	16.2		Laurent	Debauwer	INRA
	16.3	Generation of new HBM data	Adrian	Covaci	Uantwerpen
	16.4	Identifiy emerging (mixtures of) chemicals of exposure and toxicological concern in selected human samples	Roel	Vermeulen	IRAS
			Jelle	Vlaanderen	IRAS

Disclaimer

The HBM4EU project was launched in 2016 with the aim of improving the collective understanding of human exposure to hazardous chemicals and developing HBM as an exposure assessment method. The project had €74m in funding and jointly implemented by 120 partners from 28 participating countries – 24 EU member states plus Norway, Switzerland, Iceland and Israel and the European Environment Agency. One of its aims was to ensure the sustainability of HBM in the EU beyond 2021. The project ended in June 2022. The website will not be updated any longer, except the page on peer reviewed publications, but will be online until 2032.